BBY vs REPL · P/E 14, rev $41.53B vs $825.7M cap
Best Buy Co. Inc (BBY) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported BBY revenue for 2025-02-01 was $41.53B. Net income was $927.0M. Revenue was down 4.4% from 2024-02-03 to 2025-02-01. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
REPL does not have a complete income-statement cache yet.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. REPL currently screens at market cap $825.7M.
Not investment advice. Open the BBY and REPL stock pages for the full models.
Not investment advice.